Chronic Lymphocytic Leukemia | Oncology Grand Rounds Series: Part 10 — Chronic Lymphocytic Leukemia

published 2 months ago by Dr Neil Love

Proceedings from from the tenth in a series of 11 integrated webinars held in association with the 2021 ONS Annual Congress. Featuring perspectives from Drs Brian T Hill, John M Pagel and Jennifer Woyach on cases from the practices of Ms Lesley Camille Ballance, Ms Kristen E Battiato and Ms Corinne Hoffman, including the following topics: Introduction (0:00) Overview of the Current Era of Chronic Lymphocytic Leukemia (CLL) Treatment (5:37) Up-Front Treatment of CLL with a BTK (Bruton Tyrosine Kinase) Inhibitor (10:24) Case: A woman in her mid-70s with CLL who receives first-line ibrutinib — Kristen E Battiato, AGNP-C (10:34) Case: A woman in her early 50s with previously untreated CLL who receives acalabrutinib — Lesley Camille Ballance, MSN, FNP-BC (34:17) Up-Front Treatment with Obinutuzumab/Venetoclax (53:31) Case: A man in his early 70s with CLL who desires time-limited therapy— Ms Battiato (53:55) Case: A man in his late 60s with CLL and malignant pleural effusions — Corinne Hoffman, MS, APRN-CNP, AOCNP (1:02:33) Case: A woman in her mid-40s with CLL who was initially observed off treatment — Ms Ballance (1:15:43) Future Directions in CLL Therapy (1:17:30) NCPD information and select publications

more episodes from Research To Practice | Oncology Videos